Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019

Abstract Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acut...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 223; no. 11; pp. 1842 - 1854
Main Authors Ramos da Silva, Suzane, Ju, Enguo, Meng, Wen, Paniz Mondolfi, Alberto E, Dacic, Sanja, Green, Anthony, Bryce, Clare, Grimes, Zachary, Fowkes, Mary, Sordillo, Emilia M, Cordon-Cardo, Carlos, Guo, Haitao, Gao, Shou-Jiang
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases. Results Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection. Conclusions In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses. We provide an atlas of lung immunopathology of fatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, revealing unexpected broad cell tropism and infection of parenchymal, endothelial, and immune cells by SARS-CoV-2, which are associated with massive tissue damage and thromboemboli.
AbstractList Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases. Results Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection. Conclusions In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses.
Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear.BACKGROUNDCoronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear.We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases.METHODSWe performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases.Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection.RESULTSLung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection.In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses.CONCLUSIONSIn fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses.
Abstract Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases. Results Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection. Conclusions In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses. We provide an atlas of lung immunopathology of fatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, revealing unexpected broad cell tropism and infection of parenchymal, endothelial, and immune cells by SARS-CoV-2, which are associated with massive tissue damage and thromboemboli.
Author Fowkes, Mary
Ramos da Silva, Suzane
Meng, Wen
Green, Anthony
Cordon-Cardo, Carlos
Ju, Enguo
Gao, Shou-Jiang
Paniz Mondolfi, Alberto E
Guo, Haitao
Grimes, Zachary
Dacic, Sanja
Bryce, Clare
Sordillo, Emilia M
Author_xml – sequence: 1
  givenname: Suzane
  surname: Ramos da Silva
  fullname: Ramos da Silva, Suzane
  organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
– sequence: 2
  givenname: Enguo
  surname: Ju
  fullname: Ju, Enguo
  organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
– sequence: 3
  givenname: Wen
  surname: Meng
  fullname: Meng, Wen
  organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
– sequence: 4
  givenname: Alberto E
  surname: Paniz Mondolfi
  fullname: Paniz Mondolfi, Alberto E
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 5
  givenname: Sanja
  surname: Dacic
  fullname: Dacic, Sanja
  organization: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
– sequence: 6
  givenname: Anthony
  surname: Green
  fullname: Green, Anthony
  organization: Tissue and Research Pathology Core, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
– sequence: 7
  givenname: Clare
  surname: Bryce
  fullname: Bryce, Clare
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 8
  givenname: Zachary
  surname: Grimes
  fullname: Grimes, Zachary
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 9
  givenname: Mary
  surname: Fowkes
  fullname: Fowkes, Mary
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 10
  givenname: Emilia M
  surname: Sordillo
  fullname: Sordillo, Emilia M
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 11
  givenname: Carlos
  surname: Cordon-Cardo
  fullname: Cordon-Cardo, Carlos
  organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 12
  givenname: Haitao
  surname: Guo
  fullname: Guo, Haitao
  organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
– sequence: 13
  givenname: Shou-Jiang
  orcidid: 0000-0001-6194-1742
  surname: Gao
  fullname: Gao, Shou-Jiang
  email: gaos8@upmc.edu
  organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
BookMark eNqFkU1rGzEQhkVxILaTa86CXtrDxvrYD-uYOnUSMAQS57zMamdTmV1pK2kD_gv91VVxLg2UnubyPO_M8C7IzDqLhFxxds2Zkitju9aE1cFAw1Xxicx5IausLLmckTljQmR8rdQ5WYRwYIzlsqzm5Nc376Clz_iGHumNniLSJwyj8RCdP9Lno229G5BunHcW3oyfAhV0g31P996NJgwUbEsfhmGyboT4w_Xu9UiNpbvJvtK9CWHCQLcphG4hQv9X0q0JCAGpYFxdkLMO-oCX73NJXrbf95v7bPd497C52WVaVnnMhKrKNldYYKFlyaRuO960VSeaEgRDzUHCWvFKKam1akpdNRIZNlAUyVKtXJIvp9zRu5_ptlgPJuj0EFh0U6hFwbnIJVfrhH7-gB7c5G26LlG54oKpQibq-kRp70Lw2NWjNwP4Y81Z_aea-lRN_V5NEvIPgjYRonE2ejD9v7WvJ81N4_9W_AZ346gM
CitedBy_id crossref_primary_10_3389_fimmu_2022_968981
crossref_primary_10_1371_journal_pbio_3001959
crossref_primary_10_1002_jmv_28636
crossref_primary_10_1128_mbio_03011_23
crossref_primary_10_3390_biomedicines10051002
crossref_primary_10_1002_jmv_28246
crossref_primary_10_1016_j_scib_2023_08_031
crossref_primary_10_3390_v15091920
crossref_primary_10_1002_jmv_28566
crossref_primary_10_2139_ssrn_3941802
crossref_primary_10_1016_j_virol_2022_01_011
crossref_primary_10_1172_jci_insight_158126
crossref_primary_10_1016_S2213_2600_21_00408_2
crossref_primary_10_23736_S0031_0808_21_04595_X
crossref_primary_10_1186_s12985_024_02597_3
crossref_primary_10_3389_fmed_2021_637642
crossref_primary_10_1360_SSV_2021_0294
crossref_primary_10_1172_JCI148036
crossref_primary_10_1002_jmv_27244
crossref_primary_10_1111_jop_13621
crossref_primary_10_3390_vaccines9101074
crossref_primary_10_1002_jmv_28437
crossref_primary_10_1002_jmv_29009
crossref_primary_10_3389_fimmu_2022_1050478
crossref_primary_10_1002_jmv_28032
crossref_primary_10_1002_jmv_28075
Cites_doi 10.1016/j.cell.2020.04.035
10.1038/s41591-020-0901-9
10.15252/emmm.202012421
10.1093/cid/ciaa449
10.1002/jmv.25801
10.1016/j.autrev.2020.102567
10.1016/S2213-2600(20)30076-X
10.1056/NEJMoa2015432
10.1038/s41379-020-0595-z
10.1080/22221751.2020.1770129
10.1038/s41379-020-00661-1
10.1016/j.cell.2020.05.042
10.1016/S2213-2600(20)30243-5
10.1038/s41587-020-0602-4
10.1093/cid/ciaa248
10.1016/j.clim.2020.108516
10.1002/jmv.26139
10.1016/j.mehy.2020.110053
10.1038/nature03712
10.1016/j.csbj.2021.01.042
10.1002/jmv.26119
10.1016/j.cell.2020.05.006
10.1038/s41588-020-00731-9
10.1038/s41586-020-2012-7
10.1172/JCI140491
10.1016/j.chest.2020.09.259
10.1038/s41467-020-17292-4
10.1038/s41374-020-0464-x
10.1038/s41392-020-00355-9
10.1182/blood.2020007008
10.1038/s41577-020-0317-2
10.1038/s41586-020-2922-4
10.1016/S2213-2600(20)30193-4
10.1002/JLB.3COVR0520-272R
10.1128/CMR.00090-16
10.1002/jmv.25948
10.1016/j.celrep.2020.108175
10.3201/eid2609.202095
10.1111/joim.13162
10.1016/j.ebiom.2020.102833
ContentType Journal Article
Copyright The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021
The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021
– notice: The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
DBID AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1093/infdis/jiab195
DatabaseName CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 1854
ExternalDocumentID 10_1093_infdis_jiab195
10.1093/infdis/jiab195
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
3O-
4.4
41~
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYOK
ABBHK
ABDFA
ABDPE
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACGOD
ACHIC
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFQV
AFFZL
AFHKK
AFIYH
AFOFC
AFQQW
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
APWMN
AQDSO
AQKUS
AQVQM
ATGXG
AVNTJ
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
BZKNY
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MBLQV
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P0-
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TR2
VH1
W2D
W8F
WH7
X7H
X7M
Y6R
YAYTL
YKOAZ
YXANX
ZE2
ZGI
ZKG
ZXP
~91
AAYXX
AGORE
AHGBF
AJBYB
CITATION
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c374t-2976d49e5e5c3603cdf1bd7f2b6a20ec1a3a8917993cc9b6c7b3e0eba5549e9d3
ISSN 0022-1899
1537-6613
IngestDate Thu Jul 10 16:49:41 EDT 2025
Mon Jun 30 10:37:04 EDT 2025
Tue Jul 01 01:31:28 EDT 2025
Thu Apr 24 22:56:46 EDT 2025
Wed Apr 02 07:04:31 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords COVID-19
thromboemboli
SARS-CoV-2
diffuse alveolar damage
inflammation
immunofluorescence assay
immunosuppression
immunohistochemistry
IL-6
cell tropism
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c374t-2976d49e5e5c3603cdf1bd7f2b6a20ec1a3a8917993cc9b6c7b3e0eba5549e9d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6194-1742
OpenAccessLink https://academic.oup.com/jid/article-pdf/223/11/1842/38488329/jiab195.pdf
PQID 2549120953
PQPubID 41591
PageCount 13
ParticipantIDs proquest_miscellaneous_2511243198
proquest_journals_2549120953
crossref_primary_10_1093_infdis_jiab195
crossref_citationtrail_10_1093_infdis_jiab195
oup_primary_10_1093_infdis_jiab195
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-06-01
PublicationDateYYYYMMDD 2021-06-01
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-06-01
  day: 01
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: Oxford
PublicationTitle The Journal of infectious diseases
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Bost (2021070809093717000_CIT0008) 2020; 181
Best Rocha (2021070809093717000_CIT0013) 2020; 100
Wang (2021070809093717000_CIT0017) 2020; 108
Aziz (2021070809093717000_CIT0020) 2020; 92
Borczuk (2021070809093717000_CIT0028) 2020; 33
Travaglini (2021070809093717000_CIT0005) 2020; 587
Ackermann (2021070809093717000_CIT0026) 2020; 383
Qin (2021070809093717000_CIT0039) 2020; 71
Xu (2021070809093717000_CIT0003) 2020; 8
Jamilloux (2021070809093717000_CIT0023) 2020; 19
Hariri (2021070809093717000_CIT0025) 2021; 159
Liao (2021070809093717000_CIT0010) 2020; 26
Liu (2021070809093717000_CIT0040) 2020; 81
Liu (2021070809093717000_CIT0019) 2020; 12
Russell (2021070809093717000_CIT0036) 2017; 30
Carnevale (2021070809093717000_CIT0029) 2021; 93
Han (2021070809093717000_CIT0016) 2020; 9
Eimer (2021070809093717000_CIT0021) 2021; 289
Zhou (2021070809093717000_CIT0001) 2020; 579
Schaefer (2021070809093717000_CIT0015) 2020; 33
Travaglini (2021070809093717000_CIT0033) 2020; 587
Chen (2021070809093717000_CIT0018) 2020; 71
Park (2021070809093717000_CIT0038) 2020; 20
Qin (2021070809093717000_CIT0006) 2021; 19
Scherger (2021070809093717000_CIT0024) 2020; 144
Martines (2021070809093717000_CIT0035) 2020; 26
Files (2021070809093717000_CIT0043) 2021; 131
Onabajo (2021070809093717000_CIT0012) 2020; 52
Middleton (2021070809093717000_CIT0037) 2020; 136
Zhuang (2021070809093717000_CIT0011) 2020; 92
Fox (2021070809093717000_CIT0027) 2020; 8
Bryce (2021070809093717000_CIT0002) 2020
Imai (2021070809093717000_CIT0031) 2005; 436
Chua (2021070809093717000_CIT0009) 2020; 38
Luo (2021070809093717000_CIT0022) 2020; 92
De Biasi (2021070809093717000_CIT0041) 2020; 11
Leng (2021070809093717000_CIT0030) 2020; 5
Singh (2021070809093717000_CIT0004) 2020; 32
Ziegler (2021070809093717000_CIT0007) 2020; 181
Jiang (2021070809093717000_CIT0042) 2020; 218
Wang (2021070809093717000_CIT0034) 2020; 57
Hou (2021070809093717000_CIT0032) 2020; 182
Hui (2021070809093717000_CIT0014) 2020; 8
References_xml – volume: 181
  start-page: 1016
  year: 2020
  ident: 2021070809093717000_CIT0007
  article-title: SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.035
– volume: 26
  start-page: 842
  year: 2020
  ident: 2021070809093717000_CIT0010
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0901-9
– volume: 12
  start-page: e12421
  year: 2020
  ident: 2021070809093717000_CIT0019
  article-title: The role of interleukin-6 in monitoring severe case of coronavirus disease 2019
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.202012421
– volume: 71
  start-page: 1937
  year: 2020
  ident: 2021070809093717000_CIT0018
  article-title: Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa449
– volume: 92
  start-page: 814
  year: 2020
  ident: 2021070809093717000_CIT0022
  article-title: Tocilizumab treatment in COVID-19: a single center experience
  publication-title: J Med Virol
  doi: 10.1002/jmv.25801
– volume: 19
  start-page: 102567
  year: 2020
  ident: 2021070809093717000_CIT0023
  article-title: Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2020.102567
– volume: 8
  start-page: 420
  year: 2020
  ident: 2021070809093717000_CIT0003
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 383
  start-page: 120
  year: 2020
  ident: 2021070809093717000_CIT0026
  article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2015432
– volume: 33
  start-page: 2104
  year: 2020
  ident: 2021070809093717000_CIT0015
  article-title: In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19
  publication-title: Mod Pathol
  doi: 10.1038/s41379-020-0595-z
– volume: 9
  start-page: 1123
  year: 2020
  ident: 2021070809093717000_CIT0016
  article-title: Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
  publication-title: Emerg Microbes Infect
  doi: 10.1080/22221751.2020.1770129
– volume: 33
  start-page: 2156
  year: 2020
  ident: 2021070809093717000_CIT0028
  article-title: COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
  publication-title: Mod Pathol
  doi: 10.1038/s41379-020-00661-1
– volume: 182
  start-page: 429
  year: 2020
  ident: 2021070809093717000_CIT0032
  article-title: SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract
  publication-title: Cell
  doi: 10.1016/j.cell.2020.05.042
– volume: 8
  start-page: 681
  year: 2020
  ident: 2021070809093717000_CIT0027
  article-title: Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30243-5
– volume: 38
  start-page: 970
  year: 2020
  ident: 2021070809093717000_CIT0009
  article-title: COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis
  publication-title: Nat Biotechnol
  doi: 10.1038/s41587-020-0602-4
– volume: 71
  start-page: 762
  year: 2020
  ident: 2021070809093717000_CIT0039
  article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa248
– volume: 218
  start-page: 108516
  year: 2020
  ident: 2021070809093717000_CIT0042
  article-title: COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2020.108516
– volume: 92
  start-page: 2693
  year: 2020
  ident: 2021070809093717000_CIT0011
  article-title: Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection
  publication-title: J Med Virol
  doi: 10.1002/jmv.26139
– volume: 144
  start-page: 110053
  year: 2020
  ident: 2021070809093717000_CIT0024
  article-title: Rethinking interleukin-6 blockade for treatment of COVID-19
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2020.110053
– volume: 436
  start-page: 112
  year: 2005
  ident: 2021070809093717000_CIT0031
  article-title: Angiotensin-converting enzyme 2 protects from severe acute lung failure
  publication-title: Nature
  doi: 10.1038/nature03712
– volume: 81
  start-page: 318
  year: 2020
  ident: 2021070809093717000_CIT0040
  article-title: Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
  publication-title: J Infect
– volume: 19
  start-page: 1163
  year: 2021
  ident: 2021070809093717000_CIT0006
  article-title: 3044 Cases reveal important prognosis signatures of COVID-19 patients
  publication-title: Comput Struct Biotechnol J
  doi: 10.1016/j.csbj.2021.01.042
– volume: 93
  start-page: 61
  year: 2021
  ident: 2021070809093717000_CIT0029
  article-title: Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea
  publication-title: J Med Virol
  doi: 10.1002/jmv.26119
– volume: 181
  start-page: 1475
  year: 2020
  ident: 2021070809093717000_CIT0008
  article-title: Host-viral infection maps reveal signatures of severe COVID-19 patients
  publication-title: Cell
  doi: 10.1016/j.cell.2020.05.006
– volume: 52
  start-page: 1283
  year: 2020
  ident: 2021070809093717000_CIT0012
  article-title: Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
  publication-title: Nat Genet
  doi: 10.1038/s41588-020-00731-9
– volume: 579
  start-page: 270
  year: 2020
  ident: 2021070809093717000_CIT0001
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
– volume: 131
  start-page: 140491
  year: 2021
  ident: 2021070809093717000_CIT0043
  article-title: Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
  publication-title: J Clin Invest
  doi: 10.1172/JCI140491
– volume: 159
  start-page: 73
  year: 2021
  ident: 2021070809093717000_CIT0025
  article-title: Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory syndrome and H1N1 influenza: a systematic review
  publication-title: Chest
  doi: 10.1016/j.chest.2020.09.259
– volume: 11
  start-page: 3434
  year: 2020
  ident: 2021070809093717000_CIT0041
  article-title: Marked T cell activation, senescence, exhaustion and skewing towards Th17 in patients with COVID-19 pneumonia
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-17292-4
– volume: 100
  start-page: 1485
  year: 2020
  ident: 2021070809093717000_CIT0013
  article-title: Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents
  publication-title: Lab Invest
  doi: 10.1038/s41374-020-0464-x
– volume: 5
  start-page: 240
  year: 2020
  ident: 2021070809093717000_CIT0030
  article-title: Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-00355-9
– volume: 136
  start-page: 1169
  year: 2020
  ident: 2021070809093717000_CIT0037
  article-title: Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
  publication-title: Blood
  doi: 10.1182/blood.2020007008
– year: 2020
  ident: 2021070809093717000_CIT0002
  article-title: Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience
  publication-title: medRxiv [Preprint]
– volume: 20
  start-page: 351
  year: 2020
  ident: 2021070809093717000_CIT0038
  article-title: Macrophages: a Trojan horse in COVID-19?
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-020-0317-2
– volume: 587
  start-page: 619
  year: 2020
  ident: 2021070809093717000_CIT0033
  article-title: A molecular cell atlas of the human lung from single cell RNA sequencing
  publication-title: Nature
  doi: 10.1038/s41586-020-2922-4
– volume: 8
  start-page: 687
  year: 2020
  ident: 2021070809093717000_CIT0014
  article-title: Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30193-4
– volume: 587
  start-page: 619
  year: 2020
  ident: 2021070809093717000_CIT0005
  article-title: A molecular cell atlas of the human lung from single-cell RNA sequencing
  publication-title: Nature
  doi: 10.1038/s41586-020-2922-4
– volume: 108
  start-page: 17
  year: 2020
  ident: 2021070809093717000_CIT0017
  article-title: Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
  publication-title: J Leukoc Biol
  doi: 10.1002/JLB.3COVR0520-272R
– volume: 30
  start-page: 481
  year: 2017
  ident: 2021070809093717000_CIT0036
  article-title: The human immune response to respiratory syncytial virus infection
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00090-16
– volume: 92
  start-page: 2283
  year: 2020
  ident: 2021070809093717000_CIT0020
  article-title: Elevated interleukin-6 and severe COVID-19: a meta-analysis
  publication-title: J Med Virol
  doi: 10.1002/jmv.25948
– volume: 32
  start-page: 108175
  year: 2020
  ident: 2021070809093717000_CIT0004
  article-title: A single-cell RNA expression map of human coronavirus entry factors
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2020.108175
– volume: 26
  start-page: 2005
  year: 2020
  ident: 2021070809093717000_CIT0035
  article-title: Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2609.202095
– volume: 289
  start-page: 434
  year: 2021
  ident: 2021070809093717000_CIT0021
  article-title: Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study
  publication-title: J Intern Med
  doi: 10.1111/joim.13162
– volume: 57
  start-page: 102833
  year: 2020
  ident: 2021070809093717000_CIT0034
  article-title: Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102833
SSID ssj0004367
Score 2.4994519
Snippet Abstract Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive...
Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation,...
Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and...
SourceID proquest
crossref
oup
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1842
SubjectTerms ACE2
Alveoli
Angiotensin
Angiotensin-converting enzyme 2
Autopsy
Cell activation
Coronaviruses
COVID-19
Cytotoxicity
Endothelial cells
Helper cells
Immunoregulation
Inflammation
Interleukin 6
Leukocytes (neutrophilic)
Lymphocytes
Lymphocytes B
Lymphocytes T
Macrophages
Monocytes
Natural killer cells
Neutrophils
Parenchyma
Peptidyl-dipeptidase A
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
Tropism
Viral infections
Title Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
URI https://www.proquest.com/docview/2549120953
https://www.proquest.com/docview/2511243198
Volume 223
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKEIgXBANEYSCDkHiIsiV2mjSP00a1jT9CrBN7ixzbQUFdMnXtJPYR-I58F-5iJ3GnDQYvUeU67p_7-XLnu98dIW8SkYB7U2hf6ET4URoofxzp0EfGj9Cp4MxkW3yK946ig-PR8WDwy8laWi7yTXlxJa_kf6QKYyBXZMn-g2S7RWEAXoN84QoShuuNZAw-tAB7UcMX1962xJD_Fyd0fmirEcCmn4PBfV7Ol2ce83bwuG46r0_b_hj7yBGpsTexKchUVt4H0AEgx6Y1Hxi39Yk3adqMuCvtmtiOBw_31LVxe7aZLUhh0r3gDhsN6tPrxUkNo8I7LGfnwiQJXYg-0H-wbFR19W1Zd8DQRjl97Slsn5FMispJ1bOiNKwdTBevLcvCnmkwJ_fqT1xJV4-DCx2OTWulTd2q7sQHa4O7up0ZMnML4tBR1eDaMuexD3ZLdOUjxZTbgiGFRR8m30uRh6Yv6KVC3ddPvkVuM_BisMHG7v77nrbL46QtZo8_pqspyrfMClv2_hWbaYWH2RoOjTU0fUDuW_HSbYPJh2Sgq3VyxzQ2_bFO7n60KRuPyM8GpNSAlDYgpQ5IaQtS6kCLMoogpRakFEBKL4GUlhVFkFILUoogpQ1IV1ayIKUI0sfkaPJuurPn2wYgvuRJtPAZ2MoqSvVIjySPAy5VEeYqKVgeCxZoGQouxinWNORSpnksk5zrQOcCbORUp4o_IWtVXemnhOpCCiEjcG5UHCUqETJVRRHAarA0Z-GQ-O1fnElbHR-btMwyk6XBMyOSzIpkSN52809NXZhrZ74Gif110kYr0MwqmLMMz26Q2j7iQ_KqexvUP8b0YDPCxs3whICBE5COn93kc56Te_1-2yBri_lSvwCrepG_bLD5GzJ91yE
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Broad+Severe+Acute+Respiratory+Syndrome+Coronavirus+2+Cell+Tropism+and+Immunopathology+in+Lung+Tissues+From+Fatal+Coronavirus+Disease+2019&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Ramos+da+Silva%2C+Suzane&rft.au=Ju%2C+Enguo&rft.au=Meng%2C+Wen&rft.au=Paniz+Mondolfi%2C+Alberto+E&rft.date=2021-06-01&rft.pub=Oxford+University+Press&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=223&rft.issue=11&rft.spage=1842&rft.epage=1854&rft_id=info:doi/10.1093%2Finfdis%2Fjiab195&rft.externalDocID=10.1093%2Finfdis%2Fjiab195
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon